Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15099 | 29097281 | Biochimie | Steatosis and NASH in type 2 diabetes. | 2017 | Details |
| A15102 | 29094442 | Diabet Med | Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital. | 2018 | Details |
| A15109 | 29090431 | J Endocrinol Invest | Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. | 2017 | Details |
| A15123 | 29085206 | World J Gastroenterol | Nonalcoholic fatty liver disease: Evolving paradigms. | 2017 | Details |
| A15128 | 29083323 | J Clin Invest | Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. | 2017 | Details |
| A15136 | 29080046 | Curr Gastroenterol Rep | The Microbiome That Shapes Us: Can It Cause Obesity? | 2017 | Details |
| A15145 | 29074727 | Gut | Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. | 2017 | Details |
| A15147 | 29074597 | Diabetes | S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy. | 2017 | Details |
| A15156 | 29070903 | Sci Rep | Increasing Dietary Medium-Chain Fatty Acid Ratio Mitigates High-fat Diet-Induced Non-Alcoholic Steatohepatitis by Regulating Autophagy. | 2017 | Details |
| A15166 | 29065699 | Ann Clin Biochem | Performance of autotaxin as a serum marker for liver fibrosis. | 2017 | Details |
| A15174 | 29063908 | Am J Gastroenterol | Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance. | 2017 | Details |
| A15185 | 29058029 | Eur Radiol | Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study. | 2017 | Details |
| A15195 | 29055928 | Ann Hepatol | New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation. | 2018 | Details |
| A15242 | 29027308 | Pathol Int | Animal models for analyzing metabolic syndrome-associated liver diseases. | 2017 | Details |
| A15248 | 29024702 | Metabolism | Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. | 2017 | Details |
| A15273 | 28990516 | Curr Med Chem | Gut Microbiota as a Therapeutic Target for Metabolic Disorders. | 2018 | Details |
| A15274 | 28990251 | J Gastroenterol Hepatol | Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes. | 2018 | Details |
| A15280 | 28989092 | J Hepatol | Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. | 2017 | Details |
| A15289 | 28985579 | Eur J Cancer | Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale. | 2017 | Details |
| A15294 | 28981521 | PLoS One | Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus. | 2017 | Details |
| A15298 | 28975595 | Indian J Gastroenterol | Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India. | 2017 | Details |
| A15311 | 28971838 | Am J Physiol Gastrointest Liver Physiol | Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes. | 2017 | Details |
| A15313 | 28970836 | Front Immunol | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. | 2017 | Details |
| A15329 | 28965028 | Diabetes Res Clin Pract | Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disorders. | 2017 | Details |
| A15346 | 28954437 | Nutrients | Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. | 2017 | Details |
| A15348 | 28953675 | Medicine (Baltimore) | Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis. | 2017 | Details |
| A15358 | 28947922 | Clin Epigenetics | Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver. | 2017 | Details |
| A15360 | 28947134 | J Formos Med Assoc | Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease. | 2017 | Details |
| A15363 | 28945101 | DNA Cell Biol | Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases. | 2017 | Details |
| A15366 | 28942551 | J Endocrinol Invest | Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. | 2017 | Details |
| A15369 | 28942246 | Free Radic Biol Med | Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide. | 2017 | Details |
| A15377 | 28938561 | Oncotarget | Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice. | 2017 | Details |
| A15388 | 28935188 | Dig Liver Dis | Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity. | 2017 | Details |
| A15397 | 28931435 | Lipids Health Dis | Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A15406 | 28927249 | Minerva Gastroenterol Dietol | Gut microbiota, obesity and metabolic disorders. | 2017 | Details |
| A15414 | 28924123 | Intern Med | The Improvement of the Hepatic Histological Findings in a Patient with Non-alcoholic Steatohepatitis with Type 2 Diabetes after the Administration of the Sodium-glucose Cotransporter 2 Inhibitor Ipragliflozin. | 2017 | Details |
| A15420 | 28922438 | J Gastrointestin Liver Dis | Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study. | 2017 | Details |
| A15426 | 28918614 | Acta Med Iran | Modifiable Co-Morbidities Trends During Hospital Admissions for Obesity in France (2009-2014). | 2017 | Details |
| A15429 | 28918389 | J Investig Med | Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option. | 2017 | Details |
| A15433 | 28914448 | Aliment Pharmacol Ther | Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey. | 2017 | Details |
| A15444 | 28904022 | FASEB J | PI3Kγ ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic β-cell apoptosis. | 2017 | Details |
| A15447 | 28902579 | Islets | Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation. | 2017 | Details |
| A15461 | 28895641 | Exp Clin Endocrinol Diabetes | Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus. | 2017 | Details |
| A15472 | 28890481 | Endocr J | Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus. | 2017 | Details |
| A15508 | 28869506 | Int J Mol Sci | Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. | 2017 | Details |
| A15520 | 28864376 | Am J Med Sci | Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15528 | 28859855 | Gastroenterology | Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. | 2017 | Details |
| A15545 | 28849786 | Nat Rev Endocrinol | SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. | 2017 | Details |
| A15547 | 28848738 | Front Cardiovasc Med | Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance. | 2017 | Details |
| A15565 | 28840809 | Microbiol Spectr | Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. | 2017 | Details |
| A15569 | 28840257 | Diabetologia | Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. | 2017 | Details |
| A15584 | 28829976 | Diabetes Res Clin Pract | Nation-wide trends in non-alcoholic steatohepatitis (NASH) in patients with and without diabetes between 2004-05 and 2014-15 in England. | 2017 | Details |
| A15585 | 28828531 | Abdom Radiol (NY) | Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. | 2018 | Details |
| A15586 | 28828438 | Nanoscale | Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. | 2017 | Details |
| A15603 | 28817367 | Nutr Clin Pract | Nutrition Implications for Long-Term Survivors of Pancreatic Cancer Surgery [Formula: see text]. | 2017 | Details |
| A15614 | 28809804 | Nutrients | Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil. | 2017 | Details |
| A15629 | 28802062 | Hepatology | Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. | 2017 | Details |
| A15642 | 28791556 | Dig Dis Sci | The Clinical Implications of Fatty Pancreas: A Concise Review. | 2017 | Details |
| A15645 | 28790222 | Acta Med Indones | Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors. | 2017 | Details |
| A15650 | 28787358 | J Clin Gastroenterol | The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients. | 2018 | Details |
| A15682 | 28763870 | Zhonghua Gan Zang Bing Za Zhi | [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances]. | 2017 | Details |
| A15694 | 28758096 | Ann Transl Med | Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. | 2017 | Details |
| A15703 | 28751548 | Diabetes Care | Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial. | 2017 | Details |
| A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
| A15728 | 28741239 | Obes Surg | Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features. | 2018 | Details |
| A15729 | 28740738 | Int J Hepatol | Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002. | 2017 | Details |
| A15753 | 28727287 | Liver Int | Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. | 2017 | Details |
| A15756 | 28726335 | J Gastroenterol Hepatol | Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2018 | Details |
| A15763 | 28722453 | Cas Lek Cesk | [Psoriasis comorbidities]. | 2019 | Details |
| A15764 | 28722242 | Diabetes Obes Metab | Therapeutic application of GPR119 ligands in metabolic disorders. | 2017 | Details |
| A15768 | 28719078 | Diabetes Obes Metab | Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective randomized controlled pilot study. | 2017 | Details |
| A15808 | 28699503 | Curr Med Chem | Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. | 2017 | Details |
| A15814 | 28696562 | Intern Med J | Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes. | 2017 | Details |
| A15834 | 28689596 | Clin Liver Dis | Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. | 2017 | Details |
| A15836 | 28689378 | Postepy Biochem | The roles of annexins in vascular endothelium dysfunction accompanying diabetes mellitus type 2. | 2017 | Details |
| A15837 | 28688543 | Eur J Intern Med | Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer? | 2017 | Details |
| A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
| A15849 | 28683283 | Cell Metab | Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. | 2017 | Details |
| A15852 | 28680417 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in the Pathogenesis of Liver Disease. | 2017 | Details |
| A15854 | 28680048 | Sci Rep | Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. | 2017 | Details |
| A15855 | 28679676 | BMJ Open | Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study. | 2017 | Details |
| A15876 | 28676019 | Curr Vasc Pharmacol | Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15888 | 28670394 | Am J Transl Res | PFP alleviates nonalcoholic steatohepatitis fatty liver in both Apo E-/- mice and Changliver cell[S]. | 2017 | Details |
| A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
| A15898 | 28663676 | J Clin Exp Hepatol | Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? | 2017 | Details |
| A15902 | 28660151 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis. | 2017 | Details |
| A15905 | 28658824 | J Clin Diagn Res | Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. | 2017 | Details |
| A15906 | 28658094 | Medicine (Baltimore) | Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management. | 2017 | Details |
| A15914 | 28655068 | Z Gastroenterol | Potential impact of screening for fatty liver disease by transient elastography with liver stiffness and controlled attenuation parameter measurements: a pilot study. | 2017 | Details |
| A15926 | 28647765 | Abdom Radiol (NY) | Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. | 2018 | Details |
| A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
| A15945 | 28641570 | Endocr Metab Immune Disord Drug Targets | 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity. | 2017 | Details |
| A15953 | 28638584 | Middle East J Dig Dis | The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. | 2017 | Details |
| A15960 | 28637103 | Korean J Gastroenterol | [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15968 | 28634585 | J Diabetes Res | High Plasma Glucagon Levels Correlate with Waist-to-Hip Ratio, Suprailiac Skinfold Thickness, and Deep Subcutaneous Abdominal and Intraperitoneal Adipose Tissue Depots in Nonobese Asian Indian Males with Type 2 Diabetes in North India. | 2017 | Details |
| A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
| A15980 | 28628263 | Hepatol Res | Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15994 | 28621635 | Exp Clin Transplant | Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. | 2017 | Details |
| A15996 | 28621339 | Nat Rev Endocrinol | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. | 2017 | Details |